ArticleCureus2026
Recurrent Intra-abdominal Low-Grade Fibromyxoid Sarcoma Managed With Multivisceral Resections: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A mobile intra-abdominal low-grade fibromyxoid sarcoma arising from the jejunal mesentery in an adolescent: a case report and literature review.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Low-grade fibromyxoid sarcoma (LGFMS) is a rare soft-tissue sarcoma with deceptively bland histology. There is a recognized risk of late local recurrence and metastasis. Intra-abdominal presentations are uncommon and may remain clinically silent until the tumor is large, at which point complete resection can require multivisceral surgery. We report a 61-year-old woman diagnosed with intra-abdominal LGFMS in 2021. Histopathology showed classic fibromyxoid architecture with strong MUC4 expression, focal CD34 positivity, and a Ki-67 index of approximately 6%. After a margin-negative ileocecal resection, systemic therapy was administered. Multifocal intra-abdominal recurrence developed in early 2024 and was completely resected. Further recurrence occurred in 2025. The tumor involved the sigmoid colon, small bowel, urinary bladder, and spleen. Wide multivisceral resection was performed, including sigmoid colectomy, two small-bowel resections, partial cystectomy, splenectomy, and excision of additional nodules. Pathology confirmed recurrent LGFMS consistent with the original tumor, with negative surgical margins. The patient remains disease-free six months after the most recent surgery. This case underscores the propensity for persistent intra-abdominal LGFMS recurrence and supports complete surgical excision, often requiring multivisceral resection, as a key strategy for disease control in resectable recurrent disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.